Company intelligence / Profile preview

Bohus BioTech

Strömstad, Västra Götaland, Swedenbohusbiotech.com ↗

Ownership: Private
Employees: ~28
Development stage: Commercial

Overview

Bohus BioTech is a leading Swedish manufacturer specializing in high-purity, non-animal bio-fermented hyaluronic acid for medical device applications in ophthalmology, aesthetics, and orthopedics. Their products are commercialized globally and used in cataract surgery, facial enhancement, and osteoarthritis treatment.

Therapeutic areas: DermatologyRheumatologyOphthalmology
Modalities: BiologicRecombinant protein (specifically hyaluronic acid)Medical device (hyaluronic acid-based injectables and ophthalmic devices)
Industry: Therapeutic Medical Devices

Drug pipeline

3 assets

MINIVISC PLUS

Commercial

Indications: Cataract surgery

2 more assets in the full pipeline.

Request access →

Partnerships

Distributed via global network of distributors to over 60 markets worldwide

Beyond the preview

Go deeper on Bohus BioTech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bohus BioTech.

Explore the full profile